Sabby Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-940,400
Closed -$4.03M 169
2021
Q4
$4.7M Buy
+940,400
New +$7.53M 1.15% 20
2019
Q1
Sell
-138,958
Closed -$6.39M 100
2018
Q4
$6.39M Buy
138,958
+38,589
+38% +$1.86M 5.92% 11
2018
Q3
$4.45M Sell
100,369
-48,335
-33% -$2.22M 3.56% 28
2018
Q2
$5.83M Buy
148,704
+129,881
+690% +$6.56M 3.36% 21
2018
Q1
$1.36M Sell
18,823
-123,362
-87% -$9.06M 0.87% 52
2017
Q4
$9.36M Buy
142,185
+58,828
+71% +$3.17M 6.45% 24
2017
Q3
$4.18M Buy
+83,357
New +$4.02M 3.43% 45
2016
Q1
Sell
-19,000
Closed -$423K 321
2015
Q4
$423K Sell
19,000
-4,990
-21% -$126K 0.14% 245
2015
Q3
$566K Buy
+23,990
New +$1.51M 0.11% 283
2015
Q2
Sell
-5,000
Closed -$489K 358
2015
Q1
$463K Buy
+5,000
New +$323K 0.13% 239

Other funds holding ESPR